Gene · 4068
Papers4,343
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,343
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Influence of Pre-Existing Cerebral Small Vessel Disease on the Outcome of Acute Cardioembolic Stroke: A Retrospective Study. | Neuropsychiatr Dis Treat | 2022 | 35450393 | PubTator, text mining | PubMed |
| A Hydrogel as a Bespoke Delivery Platform for Stromal Cell-Derived Factor-1. | Gels | 2022 | 35448125 | PubTator, text mining | PubMed |
| GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity. | Leukemia | 2022 | 35440691 | PubTator, text mining | PubMed |
| Phosphoproteomics identifies pathways underlying the role of receptor-interaction protein kinase 3 in alcohol-associated liver disease and uncovers apoptosis signal-regulating kinase 1 as a target. | Hepatol Commun | 2022 | 35438255 | PubTator, text mining | PubMed |
| A Survey of Data Quality Measurement and Monitoring Tools. | Front Big Data | 2022 | 35434611 | PubTator, text mining | PubMed |
| CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells. | Leukemia | 2022 | 35422095 | PubTator, text mining | PubMed |
| Upregulation of p75NTR by Histone Deacetylase Inhibitors Sensitizes Human Neuroblastoma Cells to Targeted Immunotoxin-Induced Apoptosis. | Int J Mol Sci | 2022 | 35409209 | PubTator, text mining | PubMed |
| Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. | Int J Mol Sci | 2022 | 35408963 | PubTator, text mining | PubMed |
| Immune Checkpoint Receptors Signaling in T Cells. | Int J Mol Sci | 2022 | 35408889 | PubTator, text mining | PubMed |
| Self-assembling peptides-based nano-cargos for targeted chemotherapy and immunotherapy of tumors: recent developments, challenges, and future perspectives. | Drug Deliv | 2022 | 35403517 | PubTator, text mining | PubMed |
| Case Report: Novel Splicing Variant in SH2D1A in a Patient With X-Linked Lymphoproliferative Syndrome Type 1. | Front Pediatr | 2022 | 35402355 | PubTator, text mining | PubMed |
| S-acylation-dependent membrane microdomain localization of the regulatory Kvβ2.1 subunit. | Cell Mol Life Sci | 2022 | 35396942 | PubTator, text mining | PubMed |
| The Predicative Power of Learner and Teacher Variables on Flow in a Chinese Blended English as a Foreign Language Learning Context. | Front Psychol | 2022 | 35391951 | PubTator, text mining | PubMed |
| Exome sequencing of individuals with Huntington's disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset. | Nat Neurosci | 2022 | 35379994 | PubTator, text mining | PubMed |
| Using Bayesian Belief Networks to Investigate Farmer Behavior and Policy Interventions for Improved Nitrogen Management. | Environ Manage | 2022 | 35378602 | PubTator, text mining | PubMed |
| Primary Immunodeficiencies and Hematologic Malignancies: A Diagnostic Approach. | Front Immunol | 2022 | 35371103 | PubTator, text mining | PubMed |
| Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy. | Front Immunol | 2022 | 35371071 | PubTator, text mining | PubMed |
| CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy. | J Exp Clin Cancer Res | 2022 | 35361234 | PubTator, text mining | PubMed |
| Prolonged Outbreak of Carbapenem and Colistin-Resistant Klebsiella pneumoniae at a Large Tertiary Hospital in Brazil. | Front Microbiol | 2022 | 35356529 | PubTator, text mining | PubMed |
| Patients with XLP type 1 have variable numbers of NKT cells. | Br J Haematol | 2022 | 35355252 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4068/papers?page=49